Areas of Practice

Neda received her B.S. in Biochemistry from Temple University in 2009 and J.D. from University of Maryland Francis King Carey School of Law. During law school, Neda was the Editor-in-Chief of the Journal of Business and Technology Law. She also worked at University of Maryland’s Intellectual Property Law Clinic, where she helped inventors and entrepreneurs with patent prosecution, trademark registration, and contract negotiation. Prior to law school, Neda worked at Thomas Jefferson University as a Research Technician.





  • University of Maryland Francis King Carey School of Law, J.D. 2018

  • Temple University, B.S. Biochemistry, Minor in Spanish, 2009

Bar Admissions

  • New York

Professional Associations

  • New York Intellectual Property Association (NYIPLA)



  • Neda Dadpey, Issues Enforcing Nondisclosure Agreements, Ass’n for Corp. Couns.: QuickCounsel (Apr. 7, 2017)

  • Michele B. Weiss, Ethan V. Abel, Neda Dadpey & Andrew E. Aplin, FOXD3 Modulates Migration Through Direct Transcriptional Repression of TWIST1 in Melanoma, 12 Mol Cancer Res. 1314-23 (2014) (PMID: 25061102)

  • Kevin J. Basile, Ethan V. Abel, Neda Dadpey, Edward J. Hartsough, Paolo Fortina & Andrew E. Aplin, In Vivo MAPK Reporting Reveals the Heterogeneity in Tumoral Selection of Resistance to RAF Inhibitors, 73 Cancer Res. 7101-10 (2013) (PMCID: 24121492)

  • Fred M. Kaplan, Curtis H. Kugel III, Neda Dadpey, Yongping Shao, Ethan V. Abel & Andrew E. Aplin, SHOC2 and CRAF Mediate ERK1/2 Reactivation in Mutant NRAS-Mediated Resistance to RAF Inhibitor, 287 J. Biol. Chem. 41797-807 (2012) (PMCID: PMC3516728)